The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
a medical doctor and director of the FDA's Office of Cosmetics and Colors, said Thursday in a news release announcing the agency's action. The agency's proposed rule falls short of a ban on talc ...
The Food and Drug Administration is proposing a rule that cosmetic companies would have to take extra steps to ensure that ...
The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
One lot of Systane Lubricant Eye Drops Ultra PF was recalled following a consumer complaint “of foreign material observed ...
In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...
A KCK pharmaceutical company gets a cash injection that should sustain it long enough to get an ADHD drug to the FDA for ...
Gemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...
The FDA has granted breakthrough therapy designation Trodelvy for adults with extensive-stage small cell lung cancer who ...
“We are very excited to receive FDA clearance for the innovative SIMEOX 200 therapy ... Forward-Looking Statements This press release contains forward-looking statements within the meaning of the ...